BPMC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.88%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $13,714,414.59

Blueprint Medicines Insider Trading History Chart

Blueprint Medicines Share Price & Price History

^$88.90

▲ +0.52 (0.59%)

As of 04/18/2024 01:00 AM ET

Days: 30 | 90 | 365

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

Blueprint Medicines Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/28/2024	Michael Landsittel	CFO	Sell	5,000	$95.00	$475,000.00	47,286
3/20/2024	Jeffrey W. Albers	Director	Sell	25,073	$87.28	$2,188,371.44	176,050
3/15/2024	Michael Landsittel	CFO	Sell	13,734	$87.78	$1,205,570.52	47,286
3/7/2024	Christina Rossi	COO	Sell	6,070	$90.69	$550,488.30	64,306
3/7/2024	Jeffrey W. Albers	Director	Sell	11,033	$90.69	$1,000,582.77	165,017
3/7/2024	Kate Haviland	CEO	Sell	12,464	$90.69	$1,130,360.16	153,177
3/7/2024	L. Becker Hewes	Insider	Sell	3,097	$90.69	$280,866.93	46,281
3/7/2024	Michael Landsittel	CFO	Sell	5,003	$90.69	$453,722.07	56,020
3/7/2024	Tracey L. Mccain	EVP	Sell	5,194	$90.69	$471,043.86	60,498
3/4/2024	Christopher K. Murray	Insider	Sell	621	$93.65	$58,156.65	36,374
2/28/2024	Christopher K. Murray	Insider	Sell	5,000	$100.00	$500,000.00	24,495
1/25/2024	Jeffrey W. Albers	Director	Sell	25,000	$81.91	$2,047,750.00	176,050
12/22/2023	Ariel Hurley	Insider	Sell	714	$90.00	$64,260.00	14,324
12/7/2023	Christopher K. Murray	Insider	Sell	5,000	$75.00	$375,000.00	24,495
12/4/2023	Christopher K. Murray	Insider	Sell	600	$71.43	$42,858.00	24,495
11/30/2023	Jeffrey W. Albers	Director	Sell	5,000	$70.55	$352,750.00	176,050
11/24/2023	Jeffrey W. Albers	Director	Sell	15,000	$67.51	$1,012,650.00	176,050
11/3/2023	Jeffrey W. Albers	Director	Sell	1,485	$60.13	$89,293.05	176,050
11/1/2023	Jeffrey W. Albers	Director	Sell	3,881	$60.02	$232,937.62	176,050
10/26/2023	Christopher K. Murray	Insider	Sell	600	$56.40	$33,840.00	25,095
10/4/2023	Fouad Namouni	Insider	Sell	3,769	$48.06	$181,138.14	62,080
9/28/2023	Jeffrey W. Albers	Director	Sell	6,898	$50.17	$346,072.66	176,050
8/25/2023	Jeffrey W. Albers	Director	Sell	10,000	$50.16	$501,600.00	176,050
6/5/2023	Percy H. Carter	Insider	Sell	2,307	$52.06	$120,102.42	38,117
3/6/2023	Christina Rossi	COO	Sell	3,059	$45.67	$139,704.53	55,376
3/6/2023	Christopher K. Murray	Insider	Sell	1,875	$45.68	$85,650.00	25,695
3/6/2023	Jeffrey W. Albers	Director	Sell	9,793	$45.67	$447,246.31	173,450
3/6/2023	Kate Haviland	CEO	Sell	6,640	$45.69	$303,381.60	125,641
3/6/2023	Michael Landsittel	CFO	Sell	3,007	$45.68	$137,359.76	48,523
3/6/2023	Tracey L. Mccain	EVP	Sell	3,322	$45.68	$151,748.96	52,666
12/5/2022	Jeffrey W. Albers	Director	Sell	20,000	$50.09	$1,001,800.00	183,243
11/3/2022	Christina Rossi	COO	Sell	533	$45.24	$24,112.92	43,435
11/3/2022	Kate Haviland	CEO	Buy	1,100	$43.98	$48,378.00	92,281
10/4/2022	Fouad Namouni	Insider	Sell	3,477	$67.30	$234,002.10	52,797
8/24/2022	Debra Durso-Bumpus	Insider	Sell	5,000	$75.11	$375,550.00	40,836
8/22/2022	Jeffrey W. Albers	Director	Sell	8,410	$70.54	$593,241.40	183,243
8/19/2022	Jeffrey W. Albers	Director	Sell	1,590	$70.02	$111,331.80	183,243
8/16/2022	Jeffrey W. Albers	Director	Sell	20,000	$68.41	$1,368,200.00	183,243
8/8/2022	Jeffrey W. Albers	Director	Sell	10,000	$70.07	$700,700.00	183,243
8/4/2022	Christopher K. Murray	SVP	Sell	2,500	$60.44	$151,100.00	21,320
6/6/2022	Percy H. Carter	Insider	Sell	1,908	$59.76	$114,022.08	28,685
4/6/2022	Jeffrey W. Albers	CEO	Sell	5,000	$70.11	$350,550.00	183,243
3/17/2022	George Demetri	Director	Sell	10	$58.56	$585.60	5,812
3/16/2022	L. Becker Hewes	Insider	Sell	2,219	$60.00	$133,140.00
3/10/2022	Ariel Hurley	Insider	Sell	2,339	$57.15	$133,673.85
3/7/2022	Ariel Hurley	Insider	Sell	256	$56.19	$14,384.64
3/3/2022	Ariel Hurley	Insider	Sell	761	$60.27	$45,865.47
3/3/2022	Mark Alan Goldberg	Director	Buy	5,000	$59.98	$299,900.00
12/15/2021	L. Becker Hewes	Insider	Sell	729	$100.00	$72,900.00
12/13/2021	Kate Haviland	COO	Sell	1,000	$98.30	$98,300.00
12/7/2021	Tracey L. Mccain	EVP	Sell	5,000	$97.30	$486,500.00
11/15/2021	Jeffrey W. Albers	CEO	Sell	30,000	$114.50	$3,435,000.00
11/15/2021	L. Becker Hewes	Insider	Sell	729	$115.49	$84,192.21
11/3/2021	Tracey L. Mccain	EVP	Sell	5,000	$110.56	$552,800.00
10/15/2021	L. Becker Hewes	Insider	Sell	729	$102.66	$74,839.14
10/5/2021	Fouad Namouni	Insider	Sell	3,241	$98.18	$318,201.38
9/23/2021	Ariel Hurley	Insider	Sell	600	$110.00	$66,000.00
9/23/2021	Tracey L. Mccain	EVP	Sell	25,000	$108.85	$2,721,250.00
8/19/2021	Jeffrey W. Albers	CEO	Sell	25,000	$92.68	$2,317,000.00
8/17/2021	Ariel Hurley	Insider	Sell	1,350	$91.93	$124,105.50	10,747
6/28/2021	Kate Haviland	COO	Sell	1,000	$90.24	$90,240.00	54,948
5/12/2021	Jeffrey W. Albers	CEO	Sell	25,000	$92.69	$2,317,250.00	179,948

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

SEC Filings (Institutional Ownership Changes) for Blueprint Medicines (NASDAQ:BPMC)

Institutional Buying and Selling by Quarter

Blueprint Medicines Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/18/2024	Allspring Global Investments Holdings LLC	2,303	$0.22M	0.0%	N/A	0.004%
4/18/2024	Diversified Trust Co	14,472	$1.37M	0.0%	+3.6%	0.024%
4/11/2024	Clarus Wealth Advisors	2,478	$0.22M	0.1%	-25.3%	0.004%
3/27/2024	Nomura Holdings Inc.	4,500	$0.42M	0.0%	-57.1%	0.007%
3/21/2024	Healthcare of Ontario Pension Plan Trust Fund	105,900	$9.77M	0.0%	N/A	0.173%
3/11/2024	Vanguard Group Inc.	6,114,970	$564.05M	0.0%	+2.5%	9.987%
3/5/2024	Fisher Asset Management LLC	326,664	$30.13M	0.0%	-14.5%	0.534%
3/5/2024	Wellington Management Group LLP	4,276,333	$394.45M	0.1%	-15.8%	6.984%
2/28/2024	American International Group Inc.	30,228	$2.79M	0.0%	-0.4%	0.049%
2/26/2024	Teachers Retirement System of The State of Kentucky	15,300	$1.41M	0.0%	-22.4%	0.025%
2/20/2024	Eventide Asset Management LLC	312,374	$28.81M	0.5%	-28.8%	0.510%
2/20/2024	Readystate Asset Management LP	40,028	$3.69M	0.1%	N/A	0.065%
2/15/2024	Blue Owl Capital Holdings LP	71,888	$6.63M	1.2%	N/A	0.118%
2/15/2024	Virtus Fund Advisers LLC	303	$28K	0.2%	-41.5%	0.000%
2/15/2024	Virtus ETF Advisers LLC	3,892	$0.36M	0.2%	-24.9%	0.006%
2/15/2024	Virtus Investment Advisers Inc.	758	$70K	0.1%	-61.1%	0.001%
2/15/2024	Legal & General Group Plc	58,964	$5.44M	0.0%	+0.9%	0.097%
2/15/2024	Vanguard Group Inc.	6,114,970	$564.05M	0.0%	+2.5%	10.059%
2/15/2024	Voloridge Investment Management LLC	140,989	$13.01M	0.1%	N/A	0.232%
2/15/2024	Voya Investment Management LLC	102,082	$9.42M	0.0%	-34.3%	0.168%
2/15/2024	Novo Holdings A S	359,126	$33.13M	2.2%	-31.6%	0.591%
2/15/2024	Nuveen Asset Management LLC	266,758	$24.61M	0.0%	+51.3%	0.439%
2/15/2024	Price T Rowe Associates Inc. MD	5,428,955	$500.77M	0.1%	-1.2%	8.931%
2/15/2024	Profund Advisors LLC	20,628	$1.90M	0.1%	-28.0%	0.034%
2/15/2024	Granahan Investment Management LLC	167,507	$15.45M	0.5%	-26.9%	0.276%
2/15/2024	Healthcare of Ontario Pension Plan Trust Fund	105,900	$9.77M	0.0%	N/A	0.174%
2/14/2024	Royal Bank of Canada	21,529	$1.99M	0.0%	+94.4%	0.035%
2/14/2024	Pathstone Holdings LLC	3,419	$0.32M	0.0%	N/A	0.006%
2/14/2024	Creative Planning	6,827	$0.63M	0.0%	+6,727.0%	0.011%
2/14/2024	Avidity Partners Management LP	615,000	$56.73M	2.1%	-18.2%	1.012%
2/14/2024	Frontier Capital Management Co. LLC	58,467	$5.39M	0.1%	N/A	0.096%
2/14/2024	Balyasny Asset Management L.P.	5,207	$0.48M	0.0%	N/A	0.009%
2/14/2024	Nomura Holdings Inc.	4,500	$0.42M	0.0%	-57.1%	0.007%
2/14/2024	Sei Investments Co.	33,602	$3.10M	0.0%	+19.6%	0.055%
2/14/2024	Seven Eight Capital LP	4,303	$0.40M	0.0%	N/A	0.007%
2/14/2024	Sectoral Asset Management Inc.	2,470	$0.23M	0.1%	-98.5%	0.004%
2/14/2024	Schroder Investment Management Group	20,000	$1.85M	0.0%	N/A	0.033%
2/13/2024	Envestnet Asset Management Inc.	22,329	$2.06M	0.0%	+15.5%	0.037%
2/13/2024	Northern Trust Corp	573,500	$52.90M	0.0%	-2.5%	0.943%
2/13/2024	Public Employees Retirement Association of Colorado	7,420	$0.68M	0.0%	-41.4%	0.012%
2/13/2024	Cetera Advisor Networks LLC	5,073	$0.47M	0.0%	N/A	0.008%
2/13/2024	Tower Research Capital LLC TRC	7,370	$0.68M	0.0%	+689.9%	0.012%
2/13/2024	Rafferty Asset Management LLC	121,368	$11.20M	0.0%	-27.2%	0.200%
2/13/2024	NEOS Investment Management LLC	4,984	$0.46M	0.0%	N/A	0.008%
2/13/2024	The Manufacturers Life Insurance Company	135,969	$12.54M	0.0%	+3.6%	0.224%
2/13/2024	KBC Group NV	1,321	$0.12M	0.0%	N/A	0.002%
2/13/2024	California State Teachers Retirement System	61,387	$5.66M	0.0%	-8.2%	0.101%
2/12/2024	Eagle Asset Management Inc.	231,396	$21.34M	0.1%	+10.7%	0.381%
2/12/2024	Axiom Investors LLC DE	23,982	$2.21M	0.0%	N/A	0.039%
2/12/2024	Allianz Asset Management GmbH	7,500	$0.69M	0.0%	-47.6%	0.012%
2/12/2024	TD Asset Management Inc	295,916	$27.30M	0.0%	-6.4%	0.487%
2/12/2024	Steward Partners Investment Advisory LLC	7,609	$0.70M	0.0%	-28.8%	0.013%
2/9/2024	US Bancorp DE	3,541	$0.33M	0.0%	-11.1%	0.006%
2/9/2024	Franklin Resources Inc.	5,340	$0.49M	0.0%	N/A	0.009%
2/9/2024	Trexquant Investment LP	56,932	$5.25M	0.1%	N/A	0.094%
2/9/2024	BI Asset Management Fondsmaeglerselskab A S	1,029	$95K	0.0%	N/A	0.002%
2/9/2024	Norges Bank	605,951	$55.89M	0.0%	N/A	0.997%
2/8/2024	Brown Advisory Inc.	679,920	$62.72M	0.1%	+6.1%	1.118%
2/8/2024	Panagora Asset Management Inc.	270,510	$24.95M	0.1%	+2.7%	0.445%
2/8/2024	EFG Asset Management North America Corp.	26,186	$2.42M	0.5%	-2.4%	0.043%
2/8/2024	Torray Investment Partners LLC	19,235	$1.77M	0.3%	-22.4%	0.032%
2/8/2024	Vanguard Personalized Indexing Management LLC	3,476	$0.32M	0.0%	N/A	0.006%
2/7/2024	Principal Financial Group Inc.	14,510	$1.34M	0.0%	+1.7%	0.024%
2/7/2024	Dimensional Fund Advisors LP	79,979	$7.38M	0.0%	-53.4%	0.132%
2/7/2024	Dana Investment Advisors Inc.	12,537	$1.16M	0.1%	-29.6%	0.021%
2/7/2024	Teacher Retirement System of Texas	13,468	$1.24M	0.0%	-21.4%	0.022%
2/7/2024	Calton & Associates Inc.	2,423	$0.22M	0.1%	N/A	0.004%
2/7/2024	E Fund Management Co. Ltd.	6,493	$0.60M	0.0%	-24.2%	0.011%
2/6/2024	Charles Schwab Investment Management Inc.	476,063	$43.91M	0.0%	+1.6%	0.783%
2/6/2024	Amalgamated Bank	8,741	$0.81M	0.0%	-6.5%	0.014%
2/6/2024	Swiss National Bank	113,500	$10.47M	0.0%	-14.6%	0.187%
2/6/2024	Fisher Asset Management LLC	326,564	$30.12M	0.0%	-14.5%	0.537%
2/5/2024	Victory Capital Management Inc.	131,050	$12.09M	0.0%	+1,906.0%	0.216%
2/5/2024	Jackson Creek Investment Advisors LLC	15,498	$1.43M	0.5%	N/A	0.025%
2/5/2024	Van ECK Associates Corp	872	$80K	0.0%	+28.4%	0.001%
2/5/2024	Intrust Bank NA	2,679	$0.25M	0.0%	N/A	0.004%
2/5/2024	Gilbert & Cook Inc.	4,846	$0.45M	0.1%	+8.5%	0.008%
2/5/2024	Russell Investments Group Ltd.	40,002	$3.69M	0.0%	-59.5%	0.066%
2/2/2024	Headlands Technologies LLC	325	$30K	0.0%	-83.0%	0.001%
2/2/2024	Semanteon Capital Management LP	12,758	$1.18M	0.8%	N/A	0.021%
2/2/2024	State of New Jersey Common Pension Fund D	37,619	$3.47M	0.0%	-25.8%	0.062%
2/1/2024	New York State Common Retirement Fund	34,426	$3.18M	0.0%	-7.1%	0.057%
2/1/2024	California Public Employees Retirement System	86,701	$8M	0.0%	-5.0%	0.143%
1/31/2024	Xponance Inc.	4,098	$0.38M	0.0%	N/A	0.007%
1/31/2024	NBW Capital LLC	52,735	$4.86M	1.1%	-2.3%	0.087%
1/31/2024	Federated Hermes Inc.	24,043	$2.22M	0.0%	N/A	0.040%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	13,369	$1.23M	0.0%	+10.9%	0.022%
1/30/2024	Strs Ohio	6,800	$0.63M	0.0%	+94.3%	0.011%
1/29/2024	NewEdge Wealth LLC	3,565	$0.33M	0.0%	-13.4%	0.006%
1/26/2024	Mutual of America Capital Management LLC	36,602	$3.38M	0.0%	+16.6%	0.060%
1/26/2024	Peregrine Capital Management LLC	91,773	$8.47M	0.3%	-37.4%	0.151%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	37,414	$3.45M	0.0%	+0.4%	0.062%
1/24/2024	Arizona State Retirement System	16,111	$1.49M	0.0%	-6.4%	0.027%
1/24/2024	China Universal Asset Management Co. Ltd.	7,032	$0.65M	0.1%	+353.7%	0.012%
1/22/2024	Pallas Capital Advisors LLC	5,197	$0.48M	0.0%	-22.5%	0.009%
1/22/2024	Clarus Wealth Advisors	3,319	$0.31M	0.2%	N/A	0.005%
1/18/2024	Clear Harbor Asset Management LLC	3,100	$0.29M	0.0%	N/A	0.005%
1/17/2024	Assenagon Asset Management S.A.	269,658	$24.87M	0.1%	+2,788.1%	0.444%
1/16/2024	Oak Ridge Investments LLC	12,117	$1.12M	0.1%	-12.4%	0.020%
1/16/2024	Raymond James Financial Services Advisors Inc.	34,045	$3.14M	0.0%	-20.3%	0.056%

Data available starting January 2016

Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of indolent SM, and other mast cell disorders. It is also developing GAVRETO for the treatment of RET fusion-positive non-small cell lung cancer, altered thyroid carcinoma, and medullary thyroid carcinoma; BLU-945 for the treatment of epidermal growth factor receptor driven non-small-cell lung carcinoma (NSCLC); and BLU-451 to treat NSCLC in patients with epidermal growth factor receptor gene (EGFR) exon 20 insertion mutations. In addition, the company is developing BLU-782, for the treatment of fibrodysplasia ossificans progressive; BLU- 222 to treat patients with cyclin E aberrant cancers; and BLU-852 for the treatment of advanced cancers. It has collaboration and license agreements with Clementia Pharmaceuticals, Inc.; Proteovant Therapeutics; CStone Pharmaceuticals; Genentech, Inc.; Hoffmann-La Roche Inc.; and Zai Lab (Shanghai) Co., Ltd. The company was formerly known as Hoyle Pharmaceuticals, Inc. and changed its name to Blueprint Medicines Corporation in June 2011. Blueprint Medicines Corporation was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $88.90

$86.56

$91.76

50 Day Range

MA: $89.51

$73.17

$99.79

52 Week Range

Now: $88.90

$43.89

$101.00

Volume

734,926 shs

Average Volume

765,536 shs

Market Capitalization

$5.44 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.63

Who are the company insiders with the largest holdings of Blueprint Medicines?: Blueprint Medicines' top insider investors include:
Jeffrey W Albers (Director)
Kate Haviland (CEO)
Christina Rossi (COO)
Fouad Namouni (Insider)
Tracey L Mccain (EVP)
Michael Landsittel (CFO)
L Becker Hewes (Insider)
Debra Durso-Bumpus (Insider)
Percy H Carter (Insider)
Christopher K Murray (Insider)
Christopher K Murray (SVP)
Ariel Hurley (Insider)
Learn More about top insider investors at Blueprint Medicines.
Who are the major institutional investors of Blueprint Medicines?: Blueprint Medicines' top institutional investors include:
Diversified Trust Co — 0.02%
Clarus Wealth Advisors — 0.00%
Allspring Global Investments Holdings LLC — 0.00%
Learn More about top institutional investors of Blueprint Medicines stock.
Which major investors are selling Blueprint Medicines stock?: In the previous quarter, BPMC stock was sold by these institutional investors:
Clarus Wealth Advisors
Within the last year, company insiders that have sold Blueprint Medicines company stock include:
Jeffrey W Albers (Director)
Kate Haviland (CEO)
Christina Rossi (COO)
Fouad Namouni (Insider)
Tracey L Mccain (EVP)
Michael Landsittel (CFO)
L Becker Hewes (Insider)
Debra Durso-Bumpus (Insider)
Percy H Carter (Insider)
Christopher K Murray (Insider)
Learn More investors selling Blueprint Medicines stock.
Which major investors are buying Blueprint Medicines stock?: During the last quarter, BPMC stock was bought by institutional investors including:
Allspring Global Investments Holdings LLC
Diversified Trust Co